Immunity Improvement Effect of Ulmus Macrocarpa Water Extract in Adults
1 other identifier
interventional
58
0 countries
N/A
Brief Summary
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of Ulmus macrocarpa water extract for immunity improvement in relatively healthy adults. 58 subjects received 500 mg of Ulmus macrocarpa water extract per day or a placebo for 4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 healthy
Started Feb 2015
Shorter than P25 for phase_3 healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 7, 2015
CompletedFirst Posted
Study publicly available on registry
April 10, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedNovember 3, 2015
October 1, 2015
28 days
April 7, 2015
October 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum natural killer cell activity
1 month
Secondary Outcomes (4)
peripheral white blood cell
1 month
serum tumor necrosis factor-alpha level
1 month
serum interferon-gamma
1 month
serum interleukins(1betta, 2,4,8,10, and 12)
1 month
Study Arms (2)
Ulmus
ACTIVE COMPARATORUlmus macrocarpa water extract 250mg orally 2 times a day for 4 weeks
Placebo
PLACEBO COMPARATORplacebo 250mg orally 2 times a day for 4 weeks
Interventions
Eligibility Criteria
You may qualify if:
- subject has peripheral white blood cells between 4,000/Ul and 8,000/Ul
You may not qualify if:
- History of renal disease
- History of diabetes mellitus
- History of immune disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pusan National University Hospitallead
- Bio Port Korea Inc.collaborator
Related Publications (1)
Cho AR, Lee SY, Cho YH, Kim CM, Kim SG. Effects of 4-Week Intervention with Ulmus macrocarpa Hance Extract on Immune Function Biomarkers in Healthy Adults: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2018 Feb 25;2018:5690816. doi: 10.1155/2018/5690816. eCollection 2018.
PMID: 29681977DERIVED
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
April 7, 2015
First Posted
April 10, 2015
Study Start
February 1, 2015
Primary Completion
March 1, 2015
Study Completion
May 1, 2015
Last Updated
November 3, 2015
Record last verified: 2015-10